VIVUS LLC is a biopharmaceutical company focused on developing and commercializing innovative therapies for high-unmet needs, particularly in obesity, sexual health, and metabolic diseases. Their portfolio includes PANCREAZE® for exocrine pancreatic insufficiency and Qsymia® (phentermine and topiramate ER) for chronic weight management, often targeting obesity and metabolic syndrome.